Catalyst Wire Dossier Catalyst Wire Dossier

Pafuramidine Maleate (DB289)

pafuramidine · Immtech Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pafuramidine Maleate (DB289), covering 2013-03-07 to 2013-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects [Phase 1]

See pricing